Free Biopharma Daily Stock Updates - 04/16/21

$XBI $131.55 -1.5%

Want to access our searchable database of over 900 catalyst events and more? Try BiopharmIQ for 30 days free, no credit card required. Check it out here!


Pipeline Updates

$ZGNX -3.4% New findings of FINTEPLA on patients with Dravet Syndrome. source


$SNDX -2.7% AUGMENT-101 Data Update call on April 20, 2021. source


$TGTX -2.3% Positive Phase 3 trial data reported. source


$IDYA -0.5% Darovasertib monotherapy trial reports overall survival data. source


$APRE +7.6% R&D Day on 4/22/2021 will report analysis of Phase 3 completed trial. source


Finance Updates

$AZN -0.2% Receives US clearance to acquire Alexion Pharmaceuticals. source


$DTIL -1.9% Reacquires global rights to allogeneic Car T programs. source

0 comments